Protalix BioTherapeutics press release (PLX): Q1 GAAP EPS of $0.22 – Revenue of $33.75M (+233.8% Y/Y) – The Company reaffirms its previously stated 2026 revenue expectations: – Total revenue in 2026 to range from approximately $78.0 million to $83.0 million including the $25.0…
llion milestone which